Skip to main content

Table 3 Type of pre-transplant infection in patient with a VAD

From: Ventricular assist devices as bridge to heart transplantation: impact on post-transplant infections

Infections VAD patients n = 18
Total number of VAD-specific or related infectionsa n = 43
VAD-specific infections; n (%)
 • Proteus mirabilis
 • Enterobacter spp.
 • Staphylococcus aureus
  • MSSA
  • MRSA
 • Coagulase-negative Staphylococci
 • Escherichia coli
  • ESBL
 • Serratia marcescens
 • Enterococcus faecalis
  • VRE
 • Other
24 (55.8)
6 (13.9)
4 (9.3)
3 (7.0)
2 (4.7)
1 (2.3)
3 (7.0)
3 (7.0)
0 (0)
2 (4.7)
2 (4.7)
0 (0)
8 (18.6)
VAD-related infections; n (%)
 • Staphylococccus aureus
  • MSSA
  • MRSA
 • Coagulase-negative Staphylococci
 • Enterobacter spp.
 • Proteus mirabilis
 • Escherichia coli
  • ESBL
 • Enterococcus spp.
  • VRE
 • Candida spp.
 • Other
32 (74.4)
7 (16.3)
2 (4.7)
5 (11.6)
3 (7.0)
7 (16.3)
5 (11.6)
3 (7.0)
0 (0)
3 (7.0)
0 (0)
1 (2.3)
4 (9.3)
  1. ESBL extended spectrum betalactamase, MSSA methicillin susceptible Staphylococcus aureus, MRSA methicillin resistant Staphylococcus aureus, VAD ventricular-assist device, VRE vancomycin-resistant Enterococci
  2. aIn 13 cases, infection was classified as being both VAD-specific and VAD-related, therefore the addition of numbers is >100 %